The way forward for drug-resistant tuberculosis in the Philippines.

Bernardo, Madeleine Nicole G; Alberto, Isabelle Rose I; Alberto, Nicole Rose I; Eala, Michelle Ann B; Roa, Camilo C

Bernardo, Madeleine Nicole G; Alberto, Isabelle Rose I; Alberto, Nicole Rose I; Eala, Michelle Ann B; Roa, Camilo C.

Bernardo MNG; College of Medicine, Philippine General Hospital, University of the Philippines, Manila 1000, Philippines.
Alberto IRI; College of Medicine, Philippine General Hospital, University of the Philippines, Manila 1000, Philippines.
Alberto NRI; College of Medicine, Philippine General Hospital, University of the Philippines, Manila 1000, Philippines.
Eala MAB; College of Medicine, Philippine General Hospital, University of the Philippines, Manila 1000, Philippines.
Roa CC; Department of Physiology, Philippine General Hospital, University of the Philippines, Manila 1000, Philippines. Electronic address: ccroa@up.edu.ph.

Lancet Infect Dis ; 22(6): 760, 2022 06.

Article in English | MEDLINE | ID: covidwho-1864678

Subject(s)

Tuberculosis, Multidrug-Resistant; Antitubercular Agents/therapeutic use; Humans; Philippines/epidemiology; Tuberculosis, Multidrug-Resistant/drug therapy; Tuberculosis, Multidrug-Resistant/epidemiology

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Tuberculosis, Multidrug-Resistant Type of study: Observational study Limits: Humans Country/Region as subject: Asia Language: English Journal: Lancet Infect Dis Journal subject: Communicable Diseases Year: 2022 Document Type: Article Affiliation country: S1473-3099(22)00285-7

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google